AFA
VRTX icon

AA Financial Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

AA Financial Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$387K Sell
779
-140
-15% -$62K 0.05% 170
2026
Q1 		$410K Buy
919
+73
+9% +$34K 0.06% 155
2025
Q4 		$384K Buy
846
+85
+11% +$36.6K 0.07% 147
2025
Q3 		$298K Buy
761
+129
+20% +$53.9K 0.06% 154
2025
Q2 		$281K Buy
+632
New +$291K 0.06% 157

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

AA Financial Advisors's VRTX Position: Q2 2026 in Review

AA Financial Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 15% in Q2 2026, selling an estimated $62K and leaving 779 shares worth $387K. The position accounts for 0.05% of the portfolio, ranked #170.

AA Financial Advisors first reported a position in VRTX in Q2 2025 and has held it in 5 quarters since. The position peaked at $410K in Q1 2026. 334 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • AA Financial Advisors held 779 shares of Vertex Pharmaceuticals worth $387K as of Q2 2026.
  • AA Financial Advisors sold 140 Vertex Pharmaceuticals shares in Q2 2026, an estimated $62K.
  • Vertex Pharmaceuticals made up 0.05% of AA Financial Advisors's portfolio in Q2 2026, its #170 holding.
  • AA Financial Advisors first reported a position in Vertex Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • AA Financial Advisors's Vertex Pharmaceuticals position peaked at $410K in Q1 2026.
  • 334 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on AA Financial Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.